Lexaria Bioscience (LEXX) Operating Income (2017 - 2026)
Lexaria Bioscience (LEXX) recorded Operating Income of -$1.99 million in fiscal Q3 2026 (quarter ended May 31, 2026), compared with -$3.75 million a year earlier.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Operating Income (2017 - 2026) Analysis & Trends
On a TTM basis, Lexaria Bioscience's Operating Income came in at -$7.71 million as of May 31, 2026; for FY2025 (ended Aug 31, 2025), it came in at -$11.88 million.
- Across earlier fiscal years, Operating Income came in at -$5.75 million in FY2024, -$6.53 million in FY2023, -$6.62 million in FY2022 and -$5.69 million in FY2021.
- Quarterly Operating Income has ranged from -$3.75 million in fiscal Q3 2025 to -$668,005 in fiscal Q2 2024 over the past five years.
- Per Business Quant, the preceding three fiscal quarters came in at -$1.45 million (Q2 2026), -$1.57 million (Q1 2026) and -$2.69 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Lexaria Bioscience | 3.30 Mn | -12.35 Mn | - | -1.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | -1.99 Mn |
| Feb 28, 2026 | -1.45 Mn |
| Nov 30, 2025 | -1.57 Mn |
| Aug 31, 2025 | -2.69 Mn |
| May 31, 2025 | -3.75 Mn |
| Feb 28, 2025 | -2.75 Mn |
| Nov 30, 2024 | -2.69 Mn |
| Aug 31, 2024 | -2.20 Mn |
| May 31, 2024 | -1.74 Mn |
| Feb 29, 2024 | -668,005.00 |
| Nov 30, 2023 | -1.14 Mn |
| Aug 31, 2023 | -1.11 Mn |
| May 31, 2023 | -2.40 Mn |
| Feb 28, 2023 | -1.32 Mn |
| Nov 30, 2022 | -1.70 Mn |
| Aug 31, 2022 | -748,547.00 |
| May 31, 2022 | -2.42 Mn |
| Feb 28, 2022 | -1.45 Mn |
| Nov 30, 2021 | -2.00 Mn |
| Aug 31, 2021 | -1.30 Mn |
API Access
Lexaria Bioscience Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();